Gudkov AV - Search Results

1

Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas.

Kichina JV, Zeremski M, Aris L, Gurova KV, Walker E, Franks R, Nikitin AY, Kiyokawa H, Gudkov AV. Kichina JV, et al. Among authors: gudkov av. Oncogene. 2006 Feb 9;25(6):857-66. doi: 10.1038/sj.onc.1209118. Oncogene. 2006. PMID: 16170338

2

Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.

Kichina JV, Rauth S, Das Gupta TK, Gudkov AV. Kichina JV, et al. Among authors: gudkov av. Oncogene. 2003 Jul 31;22(31):4911-7. doi: 10.1038/sj.onc.1206741. Oncogene. 2003. PMID: 12894234

3

Structure and regulation of the mouse ing1 gene. Three alternative transcripts encode two phd finger proteins that have opposite effects on p53 function.

Zeremski M, Hill JE, Kwek SS, Grigorian IA, Gurova KV, Garkavtsev IV, Diatchenko L, Koonin EV, Gudkov AV. Zeremski M, et al. Among authors: gudkov av. J Biol Chem. 1999 Nov 5;274(45):32172-81. doi: 10.1074/jbc.274.45.32172. J Biol Chem. 1999. PMID: 10542254 Free article.

4

Expression of prostate specific antigen (PSA) is negatively regulated by p53.

Gurova KV, Roklin OW, Krivokrysenko VI, Chumakov PM, Cohen MB, Feinstein E, Gudkov AV. Gurova KV, et al. Among authors: gudkov av. Oncogene. 2002 Jan 3;21(1):153-7. doi: 10.1038/sj.onc.1205001. Oncogene. 2002. PMID: 11791186

5

Paradoxical role of apoptosis in tumor progression.

Gurova KV, Gudkov AV. Gurova KV, et al. Among authors: gudkov av. J Cell Biochem. 2003 Jan 1;88(1):128-37. doi: 10.1002/jcb.10382. J Cell Biochem. 2003. PMID: 12461782 Review.

6

p53 pathway in renal cell carcinoma is repressed by a dominant mechanism.

Gurova KV, Hill JE, Razorenova OV, Chumakov PM, Gudkov AV. Gurova KV, et al. Among authors: gudkov av. Cancer Res. 2004 Mar 15;64(6):1951-8. doi: 10.1158/0008-5472.can-03-1541. Cancer Res. 2004. PMID: 15026329

7

9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways.

Guo C, Gasparian AV, Zhuang Z, Bosykh DA, Komar AA, Gudkov AV, Gurova KV. Guo C, et al. Among authors: gudkov av. Oncogene. 2009 Feb 26;28(8):1151-61. doi: 10.1038/onc.2008.460. Epub 2009 Jan 12. Oncogene. 2009. PMID: 19137016

8

Localization of the candidate tumor suppressor gene ING1 to human chromosome 13q34.

Zeremski M, Horrigan SK, Grigorian IA, Westbrook CA, Gudkov AV. Zeremski M, et al. Among authors: gudkov av. Somat Cell Mol Genet. 1997 May;23(3):233-6. doi: 10.1007/BF02721376. Somat Cell Mol Genet. 1997. PMID: 9330636

9

Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells.

Gurova KV, Rokhlin OW, Budanov AV, Burdelya LG, Chumakov PM, Cohen MB, Gudkov AV. Gurova KV, et al. Among authors: gudkov av. Cancer Res. 2003 Jun 1;63(11):2905-12. Cancer Res. 2003. PMID: 12782597

10

Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.

Zou X, Ray D, Aziyu A, Christov K, Boiko AD, Gudkov AV, Kiyokawa H. Zou X, et al. Among authors: gudkov av. Genes Dev. 2002 Nov 15;16(22):2923-34. doi: 10.1101/gad.1033002. Genes Dev. 2002. PMID: 12435633 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters